OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Salicylic Acid 1%
Biore Paint & Peel Liquid Pimple Patch
- Manufacturer
- Kao USA Inc.
- Effective date
- 2025-08-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:12:13
Label at a glance#
ProductBiore
Active ingredientSALICYLIC ACID
Label structure9 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Purpose
Acne treatment
INDICATIONS & USAGE SECTION
Uses for the treatment of acne
WARNINGS SECTION
Warnings
For external use only
OTC - WHEN USING SECTION
When using this product
- Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a atime.
- Do not apply to damaged or brooken skin. Discontinue use if rash or irritation occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help of contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Clean the skin thoroughly before applying this product.
- Cover the entire affected area with a thin layer 1 to 3 times daily using the applicator tip.
- Because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor.
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Other information
store at room temperature
INACTIVE INGREDIENT SECTION
Inactive ingredients water, glycerin, pullulan, ethoxydiglycol, isodecyl neopentanoate, caesalpinia spinosa gum, inulin, capryllic/capric triglyceride, sodium hydroxide, tetrasodium glutamate diacetate, phenoxyethanol
SPL UNCLASSIFIED SECTION
Questions? 1-888-BIORE-11
biore.com
Biore is a trademark of Kao Corp.
Distributed by Kao USA Inc.
Cincinnati, OH 45214 ©2024
Made in USA of US & imported ingredients
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Biore
PAINT & PEEL
LIQUID
PIMPLE PATCH
with Salicylic Acid
Invisible Acne Treatment
NET WT
0.5 OZ (14 g)
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10596-199-05 | Biore | 14 g in 1 TUBE | LIQUID | 14 | 2 | |
| 10596-199-05 | Biore | 1 in 1 BOX | LIQUID | 1 | 2 |
Products#
Every source-derived product name is available through these pages.
- Biore
- SALICYLIC ACID
- PULLULAN
- ISODECYL NEOPENTANOATE
- GLYCERIN
- WATER
- TETRASODIUM GLUTAMATE DIACETATE
- CAPRYLIC/CAPRIC TRIGLYCERIDE
- PHENOXYETHANOL
- CAESALPINIA SPINOSA GUM
- INULIN
- ETHOXYDIGLYCOL
- SODIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10596-199 | 10596-199-05 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PULLULAN | 8ZQ0AYU1TT | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| ISODECYL NEOPENTANOATE | W60VYE24XC | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| TETRASODIUM GLUTAMATE DIACETATE | 5EHL50I4MY | IACT |
| CAPRYLIC/CAPRIC TRIGLYCERIDE | C9H2L21V7U | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| CAESALPINIA SPINOSA GUM | WL3883U2PO | IACT |
| INULIN | JOS53KRJ01 | IACT |
| ETHOXYDIGLYCOL | A1A1I8X02B | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Biore | SALICYLIC ACID | Kao USA Inc. | 2e1e1aa2-5d41-baa4-e063-6394a90ac3f2 | 2025-08-31 | Warnings | 10596-199-05 10596-199 10596019905 3dab1f50-e034-8005-e063-6394a90a808b 2e1e1aa2-5d41-baa4-e063-6394a90ac3f2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.